Alfresa Pharma contributes to the early detection and prevention of colorectal cancer in addition to the diagnosis of critical diseases essential to patient evaluation in emergency medical practice.

We develop and supply a range of best-in-class diagnostic reagents, rapid POCT products, and high-throughput analytical instruments for the clinical or laboratory setting. Our proprietary state-of-the-art colloidal-gold based nanotechnology makes the simultaneous assay of human hemoglobin and transferrin possible for the very first time. When used in combination they form a powerful diagnostic tool in fight against colorectal cancer and its prevention.

From mass screening to quick and simple diagnosis of infectious diseases and viruses, our product lines are used in clinical, laboratory, school and urgent care or crisis settings.